Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun”, “ESM”, or the “Company”) is delighted to announce that under an Emergency ...
Bristol Myers Squibb (NYSE:BMY) in collaboration with Johnson & Johnson today announced the decision to stop the Phase 3 Librexia ACS trial evaluating the efficacy and safety of milvexian when added ...